The increase in price target by Truist Securities suggests a positive outlook on OrthoPediatrics' stock value in the short term, potentially leading to an upward movement in its stock price. However, the Hold rating indicates that the analyst sees the stock as fairly valued at its current price, suggesting limited upside potential.